All Type of News
Korea Pharmaceutical Licensing Association to inaugurate on April 20.
The Korea Pharmaceutical Licensing Association will have an inaugural general meeting on April 20 for the objective of a joint development of new drugs and licensing works and knowledges shares.
The Association too...
907 expensive and frequently prescribing drugs under HIRA controls.
The expensive drug list for the 1Q of drug price review was fixed expecting it to be used for the improvement of physician's prescribing patterns.
The Health Insurnace Review Agency (HIRA) announced the expensive ...
Abbott Korea holding Reductil symposium successfully ended.Abbott Korea and Il Sung Drug company jointly took a scientific symposium on Reductil, an anti-obesity drug, for the general practitioners in Daegu for "Reductil Speaker Tour" a...
|
World 7th place of Korean pharmaceuticals by 2015.
The Korean government unveiled a blue print for the pharmaceutical industrial development to put at the world 7th place by brave investments for the R&D and the infra expansion.
The 2nd Pharmaceutical Industrial De...
KFDA to warn against asthma drugs on side effects.
The drug regulatory agency instructed an warning for the medication of asthma drugs such as GSK's Seretide (salmeterol) and formoterol preparations due to adverse reactions reported in the United States.
Taki...
Green Cross sold anti-osteoporosis technology at 160 billion won.
For the first time in the history of Korean Green Cross made a technology transfer of an experimental bio drug "rhPTH (recombinant human parathyroid hormone) to Germany at about 160 billion won (Euro dollar 130 millio...
Shinil to agree joint R&D agreement for anti-cancer drug.
Shinil pharmaceutical company announced on March 13 that the company agreed with Biorernex Inc. for the joint R&D of 'Amina-X" project, a new anti-cancer therapy after changing the name of project "BVX".
The proje...
Keunwha and Abbott Korea on strategic alliance.
Keunwha and Abbott Korea signed a strategic alliance agreement at Grand Intercontinental hotel at Samsung dong, Seoul on March 13 for a joint distribution of Hokunalin patch, an acute and chronic bronchial asthma ther...
Samil announced 30% dividends in stockholder's meeting.
Samil pharmaceutical company announced in the 53rd general shareholder's meeting at 4th floor of the company head office that 30% of dividends per stock would be paid.
Chairman Huh Kang said "We have achieved 74,40...
Sanofi to invite recruitment of phase III study for Accomplia TM.
Sanofi-Aventis will conduct clinical studies of "RIO-Asia" and "CRESCENDO" for the total 280 Korean obese patients for the assessment of 'Accomplia TM' (Rimonabant) a new anti-fat therapy especially against the abdomi...
